Copyright
©2006 Baishideng Publishing Group Co.
World J Gastroenterol. Jun 21, 2006; 12(23): 3657-3667
Published online Jun 21, 2006. doi: 10.3748/wjg.v12.i23.3657
Published online Jun 21, 2006. doi: 10.3748/wjg.v12.i23.3657
Table 1 Interpretation by PCR based methods of TPMT activity
Genotype | PCR | Risk of hematopoietictoxicity | |
238G/238G | *1/*1 | 238 GG | -7% |
460G/460G | 460 GG | ||
719A/719A | 719 AA | ||
238G/238G | *1/*3A | 238GG | -35% |
460A/460A | 460GA | ||
719A/719G | 719AG | ||
238G/238G | *1/*3B | 238GG | -35% |
460G/460A | 460GA | ||
719A/719A | 719AA | ||
238G/238G | *1/*3C | 238GG | -35% |
460G/460G | 460GG | ||
719A/719G | 719AG | ||
238G/238G | *3B/*3C | 238GG | -100% |
460G/460G | 460GG | ||
719A/719G | 719AG | ||
238G/238G | *3A/*3C | 238GG | -100% |
460A/460G | 460GA | ||
719G/719G | 719GG | ||
238G/238G | *3A/*3B | 238GG | -100% |
460A/460A | 460AA | ||
719G/719A | 719AG |
- Citation: Pierik M, Rutgeerts P, Vlietinck R, Vermeire S. Pharmacogenetics in inflammatory bowel disease. World J Gastroenterol 2006; 12(23): 3657-3667
- URL: https://www.wjgnet.com/1007-9327/full/v12/i23/3657.htm
- DOI: https://dx.doi.org/10.3748/wjg.v12.i23.3657